kabutan

Genky DrugStares, Jul-Mar (Cumulative 3Q) Ordinary Profit Increases by 5%, Jan-Mar Ordinary Profit Increases by 6%

Mon Apr 28, 2025 3:30 pm JST Earnings

9267 Genky DrugStares Co.,Ltd. 【J-GAAP】

Earnings Report

Genky DrugStares Co.,Ltd. <9267> [TSE Prime] announced its financial results after the market closed on April 28th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending June 2025 (July 2024 to March 2025) increased 5.4% from the same period last year, reaching 7.04 billion yen. However, the progress rate toward the full-year plan of 10.2 billion yen was 68.9%, almost the same as the five-year average of 69.8%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the April to June period (4Q) is expected to grow 23.0% from the same period last year, reaching 3.17 billion yen.

In the most recent three-month period, from January to March (3Q), the consolidated ordinary profit grew 6.0% from the same period last year, reaching 2.32 billion yen. However, the operating profit margin remained almost flat, changing from 4.7% in the same period last year to 4.6%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jul - Mar, 2022 124,205 4,758 5,049 3,313 109.1 71.3 Apr 24, 2023 J-GAAP
Jul - Mar, 2023 136,587 6,494 6,688 4,456 146.7 72.2 Apr 25, 2024 J-GAAP
Jul - Mar, 2024 147,383 6,839 7,046 4,873 160.3 68.9 Apr 28, 2025 J-GAAP
YoY +7.9% +5.3% +5.4% +9.4% +9.3%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2024 92,893 4,628 4,773 3,237 106.6 6.50 Jul 29, 2024 J-GAAP
Jan - Jun, 2025 Guidance 103,242 5,404 5,498 3,732 122.8 6.50 Jan 27, 2025 J-GAAP
YoY +11.1% +16.8% +15.2% +15.3% +15.2%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jun, 2023 169,059 6,709 7,079 4,764 156.9 12.50 Jul 24, 2023 J-GAAP
Jun, 2024 184,860 9,015 9,268 6,324 208.2 12.75 Jul 29, 2024 J-GAAP
Jun, 2025 Guidance 202,000 10,000 10,220 7,000 230.3 13 Jul 29, 2024 J-GAAP
YoY +9.3% +10.9% +10.3% +10.7% +10.6%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 44,620 2,107 2,193 1,369 45.1 4.7 Apr 25, 2024 J-GAAP
Apr - Jun, 2024 48,273 2,521 2,580 1,868 61.5 5.2 Jul 29, 2024 J-GAAP
Jul - Sep, 2024 50,050 2,272 2,300 1,584 52.1 4.5 Oct 28, 2024 J-GAAP
Oct - Dec, 2024 48,708 2,324 2,422 1,684 55.4 4.8 Jan 27, 2025 J-GAAP
Jan - Mar, 2025 48,625 2,243 2,324 1,605 52.8 4.6 Apr 28, 2025 J-GAAP
YoY +9.0% +6.5% +6.0% +17.2% +17.2%

Related Articles